Susan Fox, PhD, MB BCh

Translational studies of new treatments for movement disorders, including phase II and phase IIII clinical studies.
Dement Geriatr Cogn Disord. 2019 Jul 17;:1-11
Faust-Socher A, Duff-Canning S, Grabovsky A, Armstrong MJ, Rothberg B, Eslinger PJ, Meaney CA, Schneider RB, Tang-Wai DF, Fox SH, Zadikoff C, Kennedy N, Chou KL, Persad C, Litvan I, Mast BT, Gerstenecker AT, Weintraub S, Reginold W, Marras C
Parkinsonism Relat Disord. 2019 Jun 08;:
Rajalingam R, Breen DP, Chen R, Fox S, Kalia LV, Munhoz RP, Slow E, Strafella AP, Lang AE, Fasano A
Neurodegener Dis Manag. 2019 Jun;9(3):135-147
Lizarraga KJ, Al-Shorafat D, Fox S
Parkinsonism Relat Disord. 2019 Jan 10;:
Ruiz-Lopez M, Freitas ME, Oliveira LM, Munhoz RP, Fox SH, Rohani M, Rogaeva E, Lang AE, Fasano A
Mov Disord. 2019 Jan 17;:
Seppi K, Ray Chaudhuri K, Coelho M, Fox SH, Katzenschlager R, Lloret SP, Weintraub D, Sampaio C, and the collaborators of the Parkinson's Disease Update on Non-Motor Symptoms Study Group on behalf of the Movement Disorders Society Evidence-Based...
Mov Disord. 2018 Dec 21;:
Johnston TH, Geva M, Steiner L, Orbach A, Papapetropoulos S, Savola JM, Reynolds IJ, Ravenscroft P, Hill M, Fox SH, Brotchie JM, Laufer R, Hayden MR
J Neuroeng Rehabil. 2018 Nov 06;15(1):97
Li MH, Mestre TA, Fox SH, Taati B
Mov Disord Clin Pract. 2018 Jan-Feb;5(1):66-74
Udow SJ, Hobson DE, Kleiner G, Masellis M, Fox SH, Lang AE, Marras C
Ann Neurol. 2018 Oct 24;:
Espay AJ, Morgante F, Merola A, Fasano A, Marsili L, Fox SH, Bezard E, Picconi B, Calabresi P, Lang AE

Pages